Search IconSearch

Pro-Collagen Pathway Regulated by MAS and CTGF May Promote Heart Failure

Study of cardiac tissue samples suggests pharmacotherapy target


A new Cleveland Clinic Lerner Research Institute collaboration has demonstrated in human heart cells that increased expression of pro-collagen genes may lead to cardiac fibrosis and, eventually, heart failure. The findings were published in PLoS One.


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The researchers, led by the lab of Sadashiva Karnik, PhD, Department of Molecular Cardiology, studied left ventricle tissue samples from heart donors and patients undergoing heart transplantation at Cleveland Clinic.

After comparing the cardiac tissue samples and conducting a series of experiments using drugs to stimulate or silence specific cellular pathways, the researchers found that levels of two proteins — MAS and connective tissue growth factor (CTGF) — were significantly higher in patients with heart failure than in individuals with healthy hearts, and that levels of the proteins were associated with one another. The researchers also found higher levels of collagen genes in the heart failure tissue.

It is widely accepted that MAS, a G protein-coupled receptor, is associated with heart function, although researchers disagree about whether it’s protective or a risk factor for heart disease. CTGF, on the other hand, is known to regulate collagen synthesis and cardiac fibroblast proliferation, which can lead to abnormal changes in the size, shape or structure of the heart. These findings suggest that MAS and CTGF may act together to control pro-collagen expression.

Through a series of protein analyses, researchers in the Karnik lab confirmed their hypothesis. They showed that when activated, the MAS receptor promotes phosphorylation of extracellular signal-related kinases 1 and 2 (ERK1/2), which directly mediates CTGF expression.

“Our data suggest that MAS and CTGF work together to control pro-collagen expression,” Dr. Karnik says. “We believe that when these proteins are overexpressed, possibly due to a genetic variant, collagen production goes unchecked and leads to cardiac fibrosis, which makes it more difficult for the heart to pump.”

While additional research is needed, he adds, the discovery that CTFG expression is downregulated by a novel experimental inhibitor of MAS makes the MAS/CTGF/collagen pathway an ideal target for future heart failure pharmacotherapies.

The study was supported by grants from the National Heart, Lung, and Blood Institute.


Related Articles

gut microbes in intestine
Cleveland Clinic, Tufts University Research Ties Gut Microbial TMAO Pathway to Chronic Kidney Disease

Large-scale joint study links elevated TMAO blood levels and chronic kidney disease risk over time

patient in ICU
Cleveland Clinic and Purdue Seek to Revolutionize Intensive Care Through AI

Investigators are developing a deep learning model to predict health outcomes in ICUs.

Multi-Ancestry Genetic Study of Parkinson’s Disease Identifies New Risk Genes in Pursuit of Novel Treatment Targets

International collaboration is most genetically diverse study of the disease to date

Noninvasive Technology Enhances Ability to Map Brain Activity to Track Behavior Change

Preclinical work promises large-scale data with minimal bias to inform development of clinical tests

Can Boosting Hydrogen Sulfide Bolster Standard-of-Care Glioblastoma Therapy to Extend Survival?

Cleveland Clinic researchers pursue answers on basic science and clinical fronts

Microglial Immunometabolism Endophenotypes Implicated in Sex Differences in Alzheimer’s Disease

Study suggests sex-specific pathways show potential for sex-specific therapeutic approaches

23-CCC-4375928 Quantum Innovation Catalyzer 650×450
A Unique Opportunity to Explore Quantum Computing’s Potential

Cleveland Clinic launches Quantum Innovation Catalyzer Program to help start-up companies access advanced research technology

Light trails coming from African American’s head
Blood-Based Biomarkers for Alzheimer’s Disease in Women (Podcast)

Research project aims to pinpoint biomarkers that could speed diagnosis